<?xml version="1.0" encoding="UTF-8"?>
<ref id="B154-pharmaceutics-12-00171">
 <label>154.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mahajan</surname>
    <given-names>S.D.</given-names>
   </name>
   <name>
    <surname>Roy</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Yong</surname>
    <given-names>K.-T.</given-names>
   </name>
   <name>
    <surname>Ding</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Aalinkeel</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Reynolds</surname>
    <given-names>J.L.</given-names>
   </name>
   <name>
    <surname>Sykes</surname>
    <given-names>D.E.</given-names>
   </name>
   <name>
    <surname>Nair</surname>
    <given-names>B.B.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>E.Y.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Enhancing the Delivery of Anti Retroviral Drug “Saquinavir”; Across the Blood Brain Barrier Using Nanoparticles</article-title>
  <source>CHR</source>
  <year>2010</year>
  <volume>8</volume>
  <fpage>396</fpage>
  <lpage>404</lpage>
  <pub-id pub-id-type="doi">10.2174/157016210791330356</pub-id>
  <?supplied-pmid 20426757?>
  <pub-id pub-id-type="pmid">20426757</pub-id>
 </element-citation>
</ref>
